Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002727 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT00002727 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 250 participants.
The verdict
NCT00002727, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective in treating patients with stage II cancer of the vocal cord. PURPOSE: Randomized phase III trial to compare two regimens of radiation therapy in treating patients who have stage II cancer of the vocal cord.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 1996-04 |
| Est. Completion | 2016-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002727
The ClinicalTrials.gov registry entry for NCT00002727 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00002727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002727 about?
NCT00002727 is a clinical study titled "Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective in treating patients with stage II cancer of the vocal cord. PURPOSE: Randomized phase III trial to compare two regimens of radiation therapy in treating...
What is the current status of trial NCT00002727?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 1996-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00002727?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00002727?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.